Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Residual cardiovascular risk: When should we treat it?
Francisco Gómez-Delgado, Manuel Raya‐Cruz, Niki Katsiki, et al.
European Journal of Internal Medicine (2023) Vol. 120, pp. 17-24
Closed Access | Times Cited: 17

Showing 17 citing articles:

Letter to the editor: Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican cohort
Seher Şener, Yusuf Ziya Şener
Clinical Rheumatology (2025)
Closed Access | Times Cited: 1
The nonlinear association between lipoprotein(a) and major adverse cardiovascular events in acute coronary syndrome patients with three-vessel disease
Qianhui Li, Shuailei Xu, Junxian Shen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects
Antonio Greco, Simone Finocchiaro, Marco Spagnolo, et al.
Circulation (2025) Vol. 151, Iss. 6, pp. 400-415
Closed Access
Association of pericoronary inflammation with atherosclerotic plaque progression in diabetic patients with improved modifiable cardiovascular risk factors: a longitudinal CCTA cohort study
Tianhao Zhang, Hongkai Zhang, Xuelian Gao, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Association between lipoprotein(a) and coronary heart disease risk in type 2 diabetes mellitus and evaluation of statin treatment effects
Li Li, Liwu Xu
Revista da Associação Médica Brasileira (2025) Vol. 71, Iss. 1
Open Access
Multi‐Omic Insight Into the Molecular Networks in the Pathogenesis of Coronary Artery Disease
Qinghua Fang, Hong-Dan Fan, Qiaoqiao Li, et al.
Journal of the American Heart Association (2025)
Open Access
Prognostic significance of IL‐18 in acute coronary syndrome patients
Chenchun Xiong, Qiaoting Yu, Feng Gao, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 2
Open Access | Times Cited: 2
Association between residual cholesterol and sarcopenia in American adults
Jianzhao Li, Yuning Lin
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Bibliometric analysis of residual cardiovascular risk: trends and frontiers
Lin Wang, Sutong Wang, Chaoyuan Song, et al.
Journal of Health Population and Nutrition (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 4
Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?
Francesco Natale, Rosa Franzese, Luigi Marotta, et al.
Life (2024) Vol. 14, Iss. 6, pp. 679-679
Open Access | Times Cited: 1
Effects of bempedoic acid on markers of inflammation and Lp(a)
Sukhila Reddy, Abhizith Deoker
Current Opinion in Cardiology (2024)
Closed Access
Time to benefit of colchicine in patients with cardiovascular disease: A pooled analysis of randomized controlled trials
Haonan Sun, Chaoqun Huang, Linjie Li, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30408-e30408
Open Access
Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation)
Valentina Perrone, Gerardo Medea, Stefano Urbinati, et al.
Global & Regional Health Technology Assessment (2024) Vol. 11, Iss. 1, pp. 138-147
Open Access
Position Statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on Cardiac Rehabilitation and Protection Programs as a Cornerstone of Secondary Prevention after Myocardial Infarction or Revascularization
Giovanna Gallo, Maurizio Volterrani, Massimo Fini, et al.
High Blood Pressure & Cardiovascular Prevention (2024) Vol. 31, Iss. 5, pp. 417-423
Closed Access
Therapeutic potentials of peptide-derived nanoformulations in atherosclerosis: present status and future directions
Xue Liu, Weijiao Wang, Qiang Li, et al.
International Journal of Smart and Nano Materials (2024) Vol. 15, Iss. 3, pp. 610-651
Open Access
Secondary Prevention of Coronary Heart Disease Based on Residual Inflammatory Risk Assessment
海舰 骆
Advances in Clinical Medicine (2024) Vol. 14, Iss. 08, pp. 1282-1289
Closed Access
Higher remnant cholesterol increases the risk of coronary heart disease and diabetes in postmenopausal women
Yan Zhang, Kexin Song, Shuli Bi, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Page 1

Scroll to top